Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
P10 Analyst Ratings and Price Targets | NYSE:PX | Benzinga
P10 Inc has a consensus price target of $14 based on the ratings of 9 analysts. The high is $21 issued by Oppenheimer on December 12, 2024. The low is $10 issued by Keefe, Bruyette & Woods on March 1, 2024. The 3 most-recent analyst ratings were released by Stephens & Co., Barclays, and Barclays on February 13, 2025, February 13, 2025, and January 13, 2025, respectively. With an average price target of $15.67 between Stephens & Co., Barclays, and Barclays, there's an implied 30.56% upside for P10 Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Stephens & Co.
Barclays
JP Morgan
Oppenheimer
Morgan Stanley
1calculated from analyst ratings
Analyst Ratings for P10
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 02/13/2025 | Buy Now | 33.33% | Stephens & Co. | John Campbell77% | $13 → $16 | Maintains | Overweight | Get Alert |
| 02/13/2025 | Buy Now | 25% | Barclays | Benjamin Budish78% | $16 → $15 | Maintains | Overweight | Get Alert |
| 01/13/2025 | Buy Now | 33.33% | Barclays | Benjamin Budish78% | $15 → $16 | Maintains | Overweight | Get Alert |
| 01/07/2025 | Buy Now | 25% | JP Morgan | Kenneth Worthington60% | $14 → $15 | Upgrade | Neutral → Overweight | Get Alert |
| 12/12/2024 | Buy Now | 75% | Oppenheimer | Chris Kotowski83% | $17 → $21 | Maintains | Outperform | Get Alert |
| 12/09/2024 | Buy Now | 25% | Barclays | Benjamin Budish78% | $14 → $15 | Maintains | Overweight | Get Alert |
| 11/12/2024 | Buy Now | 16.67% | JP Morgan | Kenneth Worthington60% | $11 → $14 | Maintains | Neutral | Get Alert |
| 11/11/2024 | Buy Now | 8.33% | Stephens & Co. | John Campbell77% | $12 → $13 | Maintains | Overweight | Get Alert |
| 11/11/2024 | Buy Now | 8.33% | Morgan Stanley | Michael Cyprys69% | $12 → $13 | Maintains | Equal-Weight | Get Alert |
| 11/08/2024 | Buy Now | 8.33% | Keefe, Bruyette & Woods | Kyle Voigt64% | $12.5 → $13 | Reiterates | Market Perform → Market Perform | Get Alert |
| 10/22/2024 | Buy Now | — | UBS | Adam Beatty38% | $10.5 → $12 | Maintains | Neutral | Get Alert |
| 10/16/2024 | Buy Now | 33.33% | Oppenheimer | Chris Kotowski83% | $13 → $16 | Maintains | Outperform | Get Alert |
| 10/10/2024 | Buy Now | — | Morgan Stanley | Michael Cyprys69% | $10 → $12 | Maintains | Equal-Weight | Get Alert |
| 10/07/2024 | Buy Now | — | Barclays | Benjamin Budish78% | $11 → $12 | Maintains | Overweight | Get Alert |
| 08/21/2024 | Buy Now | -12.5% | UBS | Adam Beatty38% | $10 → $10.5 | Downgrade | Buy → Neutral | Get Alert |
| 08/14/2024 | Buy Now | -16.67% | Morgan Stanley | Michael Cyprys69% | $9 → $10 | Maintains | Equal-Weight | Get Alert |
| 08/12/2024 | Buy Now | -8.33% | JP Morgan | Ken Worthington71% | $9.5 → $11 | Maintains | Neutral | Get Alert |
| 08/12/2024 | Buy Now | — | Stephens & Co. | John Campbell77% | $11 → $12 | Maintains | Overweight | Get Alert |
| 08/12/2024 | Buy Now | -8.33% | Barclays | Benjamin Budish78% | $9.5 → $11 | Maintains | Overweight | Get Alert |
| 08/09/2024 | Buy Now | -20.83% | Keefe, Bruyette & Woods | Kyle Voigt64% | $9 → $9.5 | Reiterates | Market Perform → Market Perform | Get Alert |
| 03/04/2024 | Buy Now | -8.33% | Oppenheimer | Chris Kotowski83% | $17 → $11 | Maintains | Outperform | Get Alert |
| 03/04/2024 | Buy Now | -20.83% | Barclays | Benjamin Budish78% | $14 → $9.5 | Maintains | Overweight | Get Alert |
| 03/04/2024 | Buy Now | -25% | Morgan Stanley | Michael Cyprys69% | $12 → $9 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 03/01/2024 | Buy Now | -16.67% | Keefe, Bruyette & Woods | Michael Brown62% | $12 → $10 | Downgrade | Outperform → Market Perform | Get Alert |
| 03/01/2024 | Buy Now | -20.83% | JP Morgan | Ken Worthington71% | $15.5 → $9.5 | Downgrade | Overweight → Neutral | Get Alert |
| 01/24/2024 | Buy Now | — | Morgan Stanley | Michael Cyprys69% | $13 → $12 | Maintains | Overweight | Get Alert |
| 11/13/2023 | Buy Now | 25% | Oppenheimer | Chris Kotowski83% | → $15 | Reiterates | Outperform → Outperform | Get Alert |
| 11/10/2023 | Buy Now | 25% | Stephens & Co. | John Campbell77% | $16 → $15 | Maintains | Overweight | Get Alert |
| 10/18/2023 | Buy Now | 8.33% | Morgan Stanley | Michael Cyprys69% | $14 → $13 | Maintains | Overweight | Get Alert |
| 10/09/2023 | Buy Now | 25% | Oppenheimer | Chris Kotowski83% | $16 → $15 | Maintains | Outperform | Get Alert |
| 08/14/2023 | Buy Now | 16.67% | Morgan Stanley | Michael Cyprys69% | $13 → $14 | Maintains | Overweight | Get Alert |
| 08/14/2023 | Buy Now | 33.33% | Stephens & Co. | John Campbell77% | $14 → $16 | Maintains | Overweight | Get Alert |
| 08/14/2023 | Buy Now | 25% | Barclays | Benjamin Budish78% | $14 → $15 | Maintains | Overweight | Get Alert |
| 07/19/2023 | Buy Now | 8.33% | Morgan Stanley | Michael Cyprys69% | $13 → $13 | Reiterates | Overweight → Overweight | Get Alert |
| 05/17/2023 | Buy Now | 33.33% | Oppenheimer | Chris Kotowski83% | $17 → $16 | Maintains | Outperform | Get Alert |
| 05/16/2023 | Buy Now | 25% | Stephens & Co. | John Campbell77% | → $15 | Reiterates | Overweight → Overweight | Get Alert |
| 04/18/2023 | Buy Now | 20.83% | Keefe, Bruyette & Woods | Michael Brown62% | $15 → $14.5 | Maintains | Outperform | Get Alert |
| 04/13/2023 | Buy Now | 41.67% | Oppenheimer | Chris Kotowski83% | $15 → $17 | Maintains | Outperform | Get Alert |
| 03/07/2023 | Buy Now | 25% | Keefe, Bruyette & Woods | Michael Brown62% | $16 → $15 | Maintains | Outperform | Get Alert |
| 02/07/2023 | Buy Now | 25% | JP Morgan | Ken Worthington71% | $16 → $15 | Maintains | Overweight | Get Alert |
| 01/25/2023 | Buy Now | 41.67% | Oppenheimer | Chris Kotowski83% | $15 → $17 | Maintains | Outperform | Get Alert |
| 01/24/2023 | Buy Now | 16.67% | Morgan Stanley | Michael Cyprys69% | $15 → $14 | Maintains | Overweight | Get Alert |
| 12/19/2022 | Buy Now | 16.67% | Barclays | Benjamin Budish78% | $15 → $14 | Maintains | Overweight | Get Alert |
| 10/10/2022 | Buy Now | 16.67% | Barclays | Benjamin Budish78% | $15 → $14 | Maintains | Overweight | Get Alert |
| 08/31/2022 | Buy Now | 25% | Barclays | Benjamin Budish78% | → $15 | Initiates | → Overweight | Get Alert |
| 07/19/2022 | Buy Now | 25% | Morgan Stanley | Michael Cyprys69% | $16 → $15 | Maintains | Overweight | Get Alert |
| 04/20/2022 | Buy Now | 33.33% | Morgan Stanley | Michael Cyprys69% | $17 → $16 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for P10 (PX) stock?
The latest price target for P10 (NYSE:PX) was reported by Stephens & Co. on February 13, 2025. The analyst firm set a price target for $16.00 expecting PX to rise to within 12 months (a possible 33.33% upside). 20 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for P10 (PX)?
The latest analyst rating for P10 (NYSE:PX) was provided by Stephens & Co., and P10 maintained their overweight rating.
When was the last upgrade for P10 (PX)?
The last upgrade for P10 Inc happened on January 7, 2025 when JP Morgan raised their price target to $15. JP Morgan previously had a neutral for P10 Inc.
When was the last downgrade for P10 (PX)?
The last downgrade for P10 Inc happened on August 21, 2024 when UBS changed their price target from $10 to $10.5 for P10 Inc.
When is the next analyst rating going to be posted or updated for P10 (PX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of P10, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for P10 was filed on February 13, 2025 so you should expect the next rating to be made available sometime around February 13, 2026.
Is the Analyst Rating P10 (PX) correct?
While ratings are subjective and will change, the latest P10 (PX) rating was a maintained with a price target of $13.00 to $16.00. The current price P10 (PX) is trading at is $12.00, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.